Evidence map›Paper›PMID 38716449›Full record

ReviewAnalytical science advances2021

Novel technical developments in mass spectrometry imaging in 2020: A mini review.

Brooke A Dilmetz, Yea-Rin Lee, Mark R Condina, Matthew Briggs, Clifford Young, Christopher T Desire, Manuela Klingler-Hoffmann, Peter Hoffmann

Abstract readReview
In one paragraph

Review in Analytical science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Structure Analysis of Gangliosides: Mass Spectrometry Imaging.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Spatial Multiplexing and Omics.Nature reviews. Methods primers · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brooke A DilmetzFuture Industries Institute University of South Australia Adelaide Australia.
Yea-Rin LeeFuture Industries Institute University of South Australia Adelaide Australia.
Mark R CondinaFuture Industries Institute University of South Australia Adelaide Australia.
Matthew BriggsFuture Industries Institute University of South Australia Adelaide Australia.
Clifford YoungFuture Industries Institute University of South Australia Adelaide Australia.
Christopher T DesireFuture Industries Institute University of South Australia Adelaide Australia.
Manuela Klingler-HoffmannFuture Industries Institute University of South Australia Adelaide Australia.
Peter HoffmannFuture Industries Institute University of South Australia Adelaide Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The applicability of mass spectrometry imaging (MSI) has exponentially increased with the improvement of sample preparation, instrumentation (spatial resolution) and data analysis. The number of MSI publications listed in PubMed continues to grow with 378 published articles in 2020-2021. Initially, MSI was just sensitive enough to identify molecular features correlating with distinct tissue regions, similar to the resolution achieved by visual inspection after standard immunohistochemical staining. Although the spatial resolution was limited compared with other imaging modalities, the molecular intensity mapping added a new exciting capability. Over the past decade, significant improvements in every step of the workflow and most importantly in instrumentation were made, which now enables the molecular analysis at a cellular and even subcellular level. Here, we summarize the latest developments in MSI, with a focus on the latest approaches for tissue-based imaging described in 2020.

Indexed as

formalin‐fixed paraffin‐embeddedMALDImass spectrometry imagingreproducibilityworkflows

Identifiers

PMID38716449
PMCPMC10989618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.